Cadenza

Developer of small molecule compounds for demyelinating and inflammatory diseases

placeOklahoma City, Oklahoma, United States calendar_todayFounded 2022 language cadenza.bio

Social engagement

Social engagement: 964 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Plains Ventures.

Investor typeCountShare
Venture capital5100%

Recent activity

29 Jun 2026
Event
BIO International Convention 2026
22 Jun 2026
Event
BIO International Convention 2026
19 Jun 2026
Event
The Billion-Dollar Frontier: Women's Health as Smart Capital
Coming soon